Sanara MedTech
SMTI
23 hedge funds and large institutions have $10.2M invested in Sanara MedTech in 2021 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 10 increasing their positions, 3 reducing their positions, and 4 closing their positions.
233% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 3
0.53% less ownership
Funds ownership: 5.01% → 4.48% (-0.53%)
4% less funds holding
Funds holding: 24 → 23 (-1)
22% less capital invested
Capital invested by funds: $13.1M → $10.2M (-$2.89M)
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAPTRUST Financial Advisors
Raleigh,
North Carolina
|
+$465K |
| 2 |
AFM
Anson Funds Management
Dallas,
Texas
|
+$286K |
| 3 |
NRC
North Run Capital
Boston,
Massachusetts
|
+$277K |
| 4 |
DC
Diametric Capital
Boston,
Massachusetts
|
+$256K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$250K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$2.32M |
| 2 |
New York State Common Retirement Fund
Albany,
New York
|
-$448K |
| 3 |
HI
Harbour Investments
Madison,
Wisconsin
|
-$274K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$204K |
| 5 |
LCM
Laurion Capital Management
New York
|
-$93.7K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$69K | -2,000 | Closed |
|
SMTI Hedge Fund Activity: Q4 2021 in Review
23 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Sanara MedTech (SMTI) for Q4 2021, worth a combined $10.2M — down 22% from $13.1M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of SMTI and 3 opened new positions — a net loss of 1 holder — while 3 trimmed existing stakes and 10 added.
The largest buyer was CAPTRUST Financial Advisors, opening a new position worth an estimated $465K. The largest seller was Fidelity Investments, exiting entirely with an estimated $2.32M sold.
- 23 institutional investors held Sanara MedTech (SMTI) as of Q4 2021, down from 24 in Q3 2021.
- Funds reported $10.2M of Sanara MedTech stock for Q4 2021, down 22% quarter-over-quarter.
- 3 funds opened new Sanara MedTech positions in Q4 2021 and 4 closed out, a net change of -1 holder.
- The largest Sanara MedTech buyer in Q4 2021 was CAPTRUST Financial Advisors, an estimated $465K added.
- The largest Sanara MedTech seller in Q4 2021 was Fidelity Investments, an estimated $2.32M sold.
Based on aggregated 13F filings for Q4 2021.